What does C.BELLEFROID MEDICAL do?

C.BELLEFROID MEDICAL is a specialist medical practice in Herve. Private Limited, started on 29 October 2021, 1 establishment.

What is the address of C.BELLEFROID MEDICAL?

The registered office of C.BELLEFROID MEDICAL is located at Chemin du Bayon 31, 4651 Herve.

Is C.BELLEFROID MEDICAL still active?

Yes. According to the CBE (17 September 2026) C.BELLEFROID MEDICAL is active, legal situation “Normale toestand”, started on 29 October 2021.

Is C.BELLEFROID MEDICAL registered on Peppol?

Yes, C.BELLEFROID MEDICAL is registered on the Peppol network with ID 0208:0776655046.

What is the enterprise number of C.BELLEFROID MEDICAL?

The enterprise number of C.BELLEFROID MEDICAL is BE0776655046.

When was C.BELLEFROID MEDICAL founded?

C.BELLEFROID MEDICAL was founded on 29 October 2021.

Who are the directors of C.BELLEFROID MEDICAL?

According to the 2025 annual accounts, the directors of C.BELLEFROID MEDICAL are: Celine Bellefroid.

Is C.BELLEFROID MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 October 2021; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did C.BELLEFROID MEDICAL make in 2025?

C.BELLEFROID MEDICAL posted a profit after taxes of € 110,090 in financial year 2025.

What is the revenue of C.BELLEFROID MEDICAL?

As a small company, C.BELLEFROID MEDICAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 147,127.

C.BELLEFROID MEDICAL (Private Limited) - Herve

Dossier C.BELLEFROID MEDICAL, printed on 17 September 2026 from databakkes.be/en/0776655046/c-bellefroid-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

C.BELLEFROID MEDICAL from Herve, company number BE0776655046, closed financial year 2025 with a result of € 110,090 after tax. For that financial year C.BELLEFROID MEDICAL recorded a gross margin of € 147,127 and equity of € 7,836. Compared with financial year 2024, the result moved from € 160,309 to € 110,090. The company is profitable. The buffer shrank hard: equity is 70 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 18, 2026.

What it is worth Shrank hard

€ 7,836

▼ 70% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 110,090

▼ 31% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 116,437

▼ 65% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 128,500 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 417

▼ 75% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 6,788

▲ 190% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 13,366

▼ 66% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 37,025 Gross margin 2022: € 37,025 First fiscal year in the series	€ 135,115 Gross margin 2023: € 135,115 ▲ 265% vs 2022 (€ 37,025) Favourable step	€ 210,094 Gross margin 2024: € 210,094 ▲ 55% vs 2023 (€ 135,115) Favourable step	€ 147,127 Gross margin 2025: € 147,127 ▼ 30% vs 2024 (€ 210,094) Unfavourable step	▼ 30%
Profit after taxes	€ 24,832 Profit after taxes 2022: € 24,832 First fiscal year in the series	€ 102,061 Profit after taxes 2023: € 102,061 ▲ € 77,229 vs 2022 (€ 24,832) Favourable step	€ 160,309 Profit after taxes 2024: € 160,309 ▲ 57% vs 2023 (€ 102,061) Favourable step	€ 110,090 Profit after taxes 2025: € 110,090 ▼ 31% vs 2024 (€ 160,309) Unfavourable step	▼ 31%
Equity	€ 43,877 Equity 2022: € 43,877 First fiscal year in the series	€ 145,937 Equity 2023: € 145,937 ▲ 233% vs 2022 (€ 43,877) Favourable step	€ 26,246 Equity 2024: € 26,246 ▼ 82% vs 2023 (€ 145,937) Unfavourable step	€ 7,836 Equity 2025: € 7,836 ▼ 70% vs 2024 (€ 26,246) Unfavourable step	▼ 70%
Total debts	€ 26,255 Total debts 2022: € 26,255 First fiscal year in the series	€ 37,419 Total debts 2023: € 37,419 ▲ 43% vs 2022 (€ 26,255) Unfavourable step	€ 329,290 Total debts 2024: € 329,290 ▲ € 291,871 vs 2023 (€ 37,419) Unfavourable step	€ 150,105 Total debts 2025: € 150,105 ▼ 54% vs 2024 (€ 329,290) Favourable step	▼ 54%
Cash	€ 48,305 Cash 2022: € 48,305 First fiscal year in the series	€ 156,928 Cash 2023: € 156,928 ▲ 225% vs 2022 (€ 48,305) Favourable step	€ 328,817 Cash 2024: € 328,817 ▲ 110% vs 2023 (€ 156,928) Favourable step	€ 116,437 Cash 2025: € 116,437 ▼ 65% vs 2024 (€ 328,817) Unfavourable step	▼ 65%
Retained profit	€ 38,877 Retained profit 2022: € 38,877 First fiscal year in the series	€ 140,937 Retained profit 2023: € 140,937 ▲ 263% vs 2022 (€ 38,877) Favourable step	€ 21,246 Retained profit 2024: € 21,246 ▼ 85% vs 2023 (€ 140,937) Unfavourable step	€ 2,836 Retained profit 2025: € 2,836 ▼ 87% vs 2024 (€ 21,246) Unfavourable step	▼ 87%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 280,000 Dividend 2024: € 280,000 Unchanged (€ 0) Unchanged	€ 128,500 Dividend 2025: € 128,500 ▼ 54% vs 2024 (€ 280,000) Unchanged	▼ 54%
Balance sheet total	€ 70,132 Balance sheet total 2022: € 70,132 First fiscal year in the series	€ 183,356 Balance sheet total 2023: € 183,356 ▲ 161% vs 2022 (€ 70,132) Unchanged	€ 355,536 Balance sheet total 2024: € 355,536 ▲ 94% vs 2023 (€ 183,356) Unchanged	€ 157,941 Balance sheet total 2025: € 157,941 ▼ 56% vs 2024 (€ 355,536) Unchanged	▼ 56%

Key figures of C.BELLEFROID MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to C.BELLEFROID MEDICAL?

What happened at C.BELLEFROID MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 18, 2026 New annual accounts for financial year 2025: profit of € 110,090 (▼ 31% vs 2024). Source: NBB ↗
Oct 29, 2021 New establishment in Herve. KBO
Oct 29, 2021 Start of the company according to the CBE. KBO

In short

From € 24,832 profit in 2022 to € 110,090 profit in 2025.

Paid € 113,237 in corporate taxes since 2022.

Best year ever: 2024, with € 160,309 profit.

Paid out € 408,500 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at C.BELLEFROID MEDICAL? We notify you, reason included.

Follow C.BELLEFROID MEDICAL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Celine Bellefroid

C.BELLEFROID MEDICAL

Behind C.BELLEFROID MEDICAL is Celine Bellefroid.

See the full network in the app

Directors

According to the 2025 annual accounts

Celine Bellefroid

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Chemin du Bayon 31

4651 Herve

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

P.VAUCHEL MEDICAL

€ 103,184 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0776.655.046
VAT number: BE 0776.655.046
Registered office: Chemin du Bayon 31, 4651 Herve
Names & denominations: C.BELLEFROID MEDICAL · CB.MED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 October 2021
Peppol: Active · Active since 16 Sept 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗